Abbott's Architect tacrolimus assay shows medication monitoring benefits Zenopa Abbott has published data from a new clinical study that showcases the benefits of its Architect tacrolimus assay in offering accurate medication monitoring following solid organ transplantations. The device offers a standardised method of assessing ... |
